SARS-CoV-2 Mpro-IN-44
SARS-CoV-2 Mpro-IN-44 (Compound 25) is a broad-spectrum coronavirus main protease (Mpro) inhibitor. SARS-CoV-2 Mpro-IN-44 has inhibitory activity against a variety of high-risk coronaviruses (including SARS-CoV-2 and PEDV, etc.) (IC50: [1].
Product Specifications
CAS Number
3020713-53-2
UNSPSC
12352100
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Smiles
N#CC1=CC=C(OC2=CC(F)=C(Cl)C=C2CN3C(N(CC4=CC=CNC4=O)C(N/C3=N\C5=CC6=CN(C)N=C6C=C5Cl)=O)=O)S1
Molecular Formula
C29H19Cl2FN8O4S
Molecular Weight
665.48
References & Citations
[1]Liu M, et al. Identification of broad-spectrum Mpro inhibitors: a focus on high-risk coronaviruses and conserved interactions. J Enzyme Inhib Med Chem. 2025 Dec;40 (1) :2503961.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680669-500 1x 500 µL
P27 / KIP1 (SX53G8), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040253-100 1x 100 µL
Cytokeratin, LMW (AE-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400841-100 1x 100 µL
Pgp9.5 (UCHL-1) (UCHL1/841), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details